Boreal Genomics Raises $6.9M to Commercialize Nucleic Acid Purification System

The company seeks to accelerate commercialization of Aurora, the latest version of a Boreal nucleic acid purification platform that uses a technology called synchronous coefficient of drag alteration.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.